Medicare Part D coverage · fluocinolone acetonide · RxCUI 1191301
fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic]
Per the CMS 2026 Part D formulary file, fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic] is covered by 26 Medicare Part D plans (0.5% of enrollable products), averaging Tier 3, with prior authorization required on 0% of covering formularies.
- 0.5%
- Plan coverage
- 26
- Plans covering
- T3
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic]
Per the CMS 2026 Part D formulary file, fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic] (RxNorm concept RXCUI 1191301, generic name fluocinolone acetonide) appears on 4 distinct formulary files spanning 26 Medicare Part D plan offerings - 0.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 3 to Tier 3, with a cross-plan average of Tier 3.
Real-world access to fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 80,799 Part D beneficiaries filled fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic] in 2023, with total plan-and-beneficiary spending of $9,567,147 and an average per-beneficiary annual cost of $118.41. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic] today.
Coverage Details
- Formularies covering
- 4
- Plans covering
- 26
- Coverage rate
- 0.5%
- Tier range
- Tier 3, Preferred Brand
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 80,799
- Total spending
- $9,567,147
- Avg per beneficiary
- $118.41
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic]
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| Blue Shield Rx Plus (PDP) | California Physicians' Service | T3 | No | No | $199.70 | - |
| Blue Shield Rx Enhanced (PDP) | California Physicians' Service | T3 | No | No | $227.80 | - |
Medicare Advantage Plans (MA-PD) Covering fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic]
24 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| DrMax (HMO) | Doctors Healthcare Plans, Inc. | T3 | No | $0 | FL |
| DrExtraCare (HMO C-SNP) | Doctors Healthcare Plans, Inc. | T3 | No | $0 | FL |
| DrSelect (HMO) | Doctors Healthcare Plans, Inc. | T3 | No | $0 | FL |
| DrSelect-CFL (HMO) | Doctors Healthcare Plans, Inc. | T3 | No | $0 | FL |
| DrPlatinum-CFL (HMO D-SNP) | Doctors Healthcare Plans, Inc. | T3 | No | $0 | FL |
| DrTotalCare-CFL (HMO C-SNP) | Doctors Healthcare Plans, Inc. | T3 | No | $0 | FL |
| DrElite-SFL (HMO) | Doctors Healthcare Plans, Inc. | T3 | No | $0 | FL |
| Blue Shield 65 Plus (HMO) | California Physicians' Service | T3 | No | $0 | CA |
| Blue Shield 65 Plus (HMO) | California Physicians' Service | T3 | No | $0 | CA |
| Blue Shield 65 Plus Plan 2 (HMO) | California Physicians' Service | T3 | No | $0 | CA |
| Blue Shield 65 Plus (HMO) | California Physicians' Service | T3 | No | $0 | CA |
| Blue Shield 65 Plus (HMO) | California Physicians' Service | T3 | No | $0 | CA |
| Blue Shield 65 Plus (HMO) | California Physicians' Service | T3 | No | $0 | CA |
| Blue Shield 65 Plus (HMO) | California Physicians' Service | T3 | No | $0 | CA |
| Blue Shield 65 Plus Choice Plan (HMO) | California Physicians' Service | T3 | No | $0 | CA |
| Blue Shield Inspire (HMO) | California Physicians' Service | T3 | No | $0 | CA |
| Blue Shield Inspire (HMO) | California Physicians' Service | T3 | No | $0 | CA |
| Blue Shield TotalDual Plan (HMO D-SNP) | California Physicians' Service | T3 | No | $0 | CA |
| Blue Shield AdvantageOptimum Plan (HMO) | California Physicians' Service | T3 | No | $0 | CA |
| Blue Shield AdvantageOptimum Plan 1 (HMO) | California Physicians' Service | T3 | No | $0 | CA |
Show the next 4 plans
| DrFlex (HMO D-SNP) | Doctors Healthcare Plans, Inc. | T3 | No | $1.10 | FL |
| DrPlus (HMO D-SNP) | Doctors Healthcare Plans, Inc. | T3 | No | $4.80 | FL |
| Blue Shield Advantage (HMO) | California Physicians' Service | T3 | No | $20.00 | CA |
| Blue Shield Inspire (HMO) | California Physicians' Service | T3 | No | $46.90 | CA |
Frequently Asked Questions
Is fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic] covered by Medicare Part D?
Yes, fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic] is covered by 26 Medicare Part D plans (0.5% of all Part D formularies).
What tier is fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic] on Medicare Part D plans?
fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic] averages Tier 3 across Part D plans, ranging from Tier 3 to Tier 3.
Does fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic] require prior authorization?
0% of Part D formularies require prior authorization for fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic]?
In 2023, total Medicare Part D spending on fluocinolone acetonide 0.1 MG/ML Otic Solution [Dermotic] was $9,567,147, covering 80,799 beneficiaries. The average spend per beneficiary was $118.41.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA